Statera Biopharma, Inc. Debt Securities, Held-to-maturity, Current
Statera Biopharma, Inc. had Debt Securities, Held-to-maturity, Current of $503.81 thousand as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:HeldToMaturitySecuritiesCurrent · last filed 2019-03-07
- 2018-12-31: Debt Securities, Held-to-maturity, Current $503.81K.
- 2017-12-31: Debt Securities, Held-to-maturity, Current $4.56M.
- 2016-12-31: Debt Securities, Held-to-maturity, Current $8.34M.
- 2015-12-31: Debt Securities, Held-to-maturity, Current $13.70M.
| Period end | Debt Securities, Held-to-maturity, Current |
|---|---|
| 2018-12-31 | $503.81K 10-K · filed 2019-03-07 |
| 2017-12-31 | $4.56M 10-K · filed 2019-03-07 |
| 2016-12-31 | $8.34M 10-K · filed 2018-03-06 |
| 2015-12-31 | $13.70M 10-K · filed 2017-02-22 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-23 |
| 2014-09-30 | $1.27M 10-Q · filed 2014-11-10 |
| 2014-03-31 | $280.21K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $305.54K 10-K · filed 2015-02-27 |
| 2012-12-31 | $2.63M 10-K · filed 2014-03-17 |